NASDAQ:NVAX Novavax, Inc.
Long term PT 360 and higher
Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to...
If you haven`t bought NVAX during the Covid Pandemic:
Then analyzing the options chain and the chart patterns of NVAX Novavax prior to the earnings report this week,
I would consider purchasing the 7.50usd strike price Calls with
an expiration date of 2024-1-19,
for a premium of approximately $0.87.
If these options prove to be profitable prior to the earnings...
Hi Everybody.
Novavax just has good news in the UK, which can be the trigger to push the price higher.
I like to find Gaps that are usually filled up by time.
There are lower gaps as well, but I think from here we go up, what are your thoughts?
10x can be for the next few months if that theory plays out.
Leave a comment.
If you haven`t bought NVAX during the pandemic:
Then you need to know that NVAX Novavax's recent achievements in gaining full marketing authorization for its COVID-19 vaccine, Nuvaxovid, in the UK and Singapore, alongside its availability in major U.S. pharmacies, have ignited optimism among investors. These milestones signify a bright future for NVAT...
NVAX has started distributing millions of COVID-19 vaccine shots. However, NVAX is trending back down towards the buy zone. I think that this will present a great second chance buy opportunity after NVAX's recent rally to $8. The markets have been affected by the new Israel Palestine conflict. Other key events this week are September PPI inflation data and Fed...
Hi guys! So lately theres been some buzz on a particular variant, increased cases of hospitalizations and government backing. At risk population that require vaccinations/ boosters will always exist. Therefore, i believe this fact along with various technical analysis findings can make companies such as Biontech, Moderna and even not as famous Novavax potential...
NVAX has been one of our best performing stocks that has been trading in an accumulation range between $7 and $9. I believe that NVAX is trending for an upward breakout in Q4. The FDA has approved NVAX's COVID vaccine for patient ages 12+, and the European Union is set to make a decision in October. I believe that NVAX has promising short-term outlook that will...
NVAX has received solid support in the buy zone ($6.50-$7) throughout Q3. I think NVAX will have its breakout in Q4 and the key resistance targets are the $16.21 and $23.13 price levels. October will be an important month for NVAX with the European Union deciding whether to approve the NVAX COVID vaccine. Germany already has an interest in placing an order for...
I started an Investment Gems series with hopes of finding the best long-term investment opportunities in the bear market. NVAX was by far my favorite investment opportunity because I see a clear path for NVAX to climb from $6-7 price levels to $288. As discussed in my previous analysis, NVAX has reached this $288 price target 3 times in the past and I believe that...
3D chart showing incredible symmetry just below VMA.
Daily holding well above 60VMA
Another daily close above current level would confirm a breakout with possible targets at 11 and 17.
Bear case: for the volume seen last couple of days, price should have moved up, so makes me wary of fade below 8.
Disclosure: I am long via commons with 8 as the stop...
Following weekly chart.
- Now covid variant on the way
- Novavax vaccine is working for the new variant, if it spreads more, company is on a way to make good money.
And technically we're on a deep.
TP1 - Following EMA100 for a first target
TP2 - 80 is a nice area as a fibonacci level and a resistance.
TP3 - Planinng to hold some till 250, it reached 2 times...
NVAX could be forming a large Weekly Inverse Head & Shoulder.
If this pattern is to break out, it likely means we have new Covid strains and potential lockdowns.
AX buy range was between $6.50 and $7. I was also willing to DCA down to $5.50.
After entering the buy zone, bullish news came out and NVAX had a 55% pump to $10.
$8 was acting as a local support level and NVAX is showing continued bullishness for now.
This is a long term hold for me (3-5 years with a long term price target around $288)
Target Price
TP 1...
NVAX popped today for a price jump of more than 20%. Canada agreed to pay out on a contract
for COVID vaccines it now does not want in the amount of $350M. This is hardly enough to
the fundamentals of the company overall. So the question arises, have traders and / or
investors overreacted to a one time bonus which is essentially revenue without overhead...
NVAX has had significant down trending over a wide range of time. On the 4H chart it seems to
be pivoting from a swing bottom 3-4 days ago. This is accompanied by a cross of the MACD
lines under the histogram on that indicator and a flip of volatility on the relative volatility
indicator. NVAX has been subject to significant short selling. Price is presently...
NVAX is trading near lows and forming a bottom
as long as rising trendline and 7$ area is kept there is a possibility for a move higher
there is high short float as well
targets on chart
